Venture Market News for August 7, 2018
- Chemetall announces new Tech Cool® products to meet the comprehensive needs of metalworking operations.
NEW PROVIDENCE, N.J., Aug. 7, 2018 /CNW/ — The Surface Treatment global business unit of the Coatings division of BASF (OTCQX: BASFY), operating under the Chemetall brand, advances the standards with two new products, Tech Cool® 35058 and Tech Cool 35037. These metalworking coolants join the innovative and award-winning Tech Cool line of metalworking fluids for metal fabricators.
- Know Labs Announces Laboratory Comparison Tests of its Non-Invasive Blood Glucose Technology and the DexCom G5®
Know Labs, Inc. (OTCQB: KNWN) – a provider of identification, authentication and diagnostic solutions, released today a video overview of comparison tests of the Company’s invention of a new way to detect blood glucose non-invasively and the DexCom G5®. In the video, Company CEO Phil Bosua discusses the breakthrough and highlights a comparison of the Know Labs Bio-RFID™ technology with an industry leading continuous glucose monitor from DexCom, Inc. (DXCM).
- MusclePharm(R) Corporation to Hold 2018 Second Quarter Conference Call on August 14, 2018
BURBANK, CA / ACCESSWIRE / August 7, 2018 / MusclePharm® Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, will report financial results for the three and six months ended June 30, 2018 after market close on Tuesday, August 14, 2018. MusclePharm management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.
- Drone USA Announces September Launch of New Website and E-commerce Store
WEST HAVEN, CT / ACCESSWIRE / August 7, 2018 / Drone USA, Inc. (OTCQB: DRUS) (“Drone USA” or the “Company”), a service provider, reseller and distributor of drones and products to the U.S. Government, announced today that it is launching a new website and E-commerce store in September 2018.
- GT Biopharma Announces Completion of $5.1 Million Convertible Debt Financing
LOS ANGELES, CA / ACCESSWIRE / August 7, 2018 / GT Biopharma Inc. (OTCQB: GTBP; Euronext Paris: GTBP) an immuno-oncology biotechnology company focused on innovative treatments based on the company’s proprietary platforms, today announced that on August 2, 2018 it completed a private placement of convertible debentures for gross proceeds of $5,140,000.
Connect with 24/7 Market News on social media:
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.
24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. 24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
For further information on 24/7 Market News, please go to www.247marketnews.com
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan,” or “planned,” “will,” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and 24/7MN undertakes no obligation to update such statements
24/7 Market News